and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.
related to rofecoxib which involved guest authorship
and ghost-writing alike.
was defined by Wager and Kleinert (2011) as authorship granted to an individual who does not meet ethical standards for authorship, because of his or her "seniority, reputation or supposed influence." Guest authorship
may be granted when authors believe having a senior researcher on a manuscript enhances their own prestige or the chances of a manuscript being accepted for publication.
They include guest authorship
, gift authorship, and ghost authorship.
Ross et al., Guest Authorship
and Ghostwriting in Publications Related to Rofecoxib: A Case Study of Industry Documents from Rofecoxib Litigation, JAMA (Apr.